Ultrasound may spot arthritis Flare-Ups before symptoms start
NCT ID NCT01765374
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether ultrasound could detect signs of rheumatoid arthritis (RA) relapse before symptoms appear in patients treated with rituximab. Thirty adults with RA who had not responded to at least one TNF-blocking drug were included. Researchers used ultrasound to measure joint inflammation over time, aiming to catch relapses earlier than standard clinical checks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Rituximab
What this could lead to
If successful, this approach could help doctors detect rheumatoid arthritis flare-ups earlier, allowing for timely treatment adjustments.
What could go wrong
This is a small, completed Phase 4 study with only 30 participants, so results may not apply to everyone. Ultrasound detection may not reliably predict clinical symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Rheumatology
Le Havre, 76290, France
-
Department of Rheumatology CHG Elbeuf
Saint-Aubin-lès-Elbeuf, 76410, France
-
Department of Rheumatology, CHU de Caen
Caen, 14033, France
-
Department of rheumatology
Rouen, 76031, France
-
Normandy
Caen, Le Havre, Rouen, Elbeuf, France